Targeted sensitization of tumor cells for radiation through monocarboxylate transporters 1 and 4 inhibition in vitro

[1]  H. Messmann,et al.  S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs , 2020, Der Chirurg.

[2]  B. Telfer,et al.  Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters , 2018, Scientific Reports.

[3]  A. Neff,et al.  Comparative metabolic analysis in head and neck cancer and the normal gingiva , 2018, Clinical Oral Investigations.

[4]  Juan Wang,et al.  Stromal-epithelial lactate shuttle induced by tumor-derived interleukin-1β promotes cell proliferation in oral squamous cell carcinoma , 2017, International journal of molecular medicine.

[5]  Masaki Kobayashi,et al.  Involvement of Monocarboxylate Transporter 4 Expression in Statin-Induced Cytotoxicity. , 2016, Journal of pharmaceutical sciences.

[6]  T. Schroeder,et al.  Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years , 2016, Clinical Oral Investigations.

[7]  Toshio Matsumoto,et al.  Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation , 2015, Oncotarget.

[8]  N. Taghavi,et al.  Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. , 2015, Archives of Iranian medicine.

[9]  B. Telfer,et al.  Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport , 2014, Molecular Cancer Therapeutics.

[10]  K. Chijiiwa,et al.  Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Mark A. Hall,et al.  Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. , 2014, Cancer research.

[12]  M. Geng,et al.  Monocarboxylate Transporter 4 Facilitates Cell Proliferation and Migration and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma Patients , 2014, PloS one.

[13]  Paul D. Smith,et al.  Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer , 2013, Clinical Cancer Research.

[14]  T. Takemasa,et al.  Effect of AMPK activation on monocarboxylate transporter (MCT)1 and MCT4 in denervated muscle , 2013, The Journal of Physiological Sciences.

[15]  S. Bojesen,et al.  Statin use and reduced cancer-related mortality. , 2012, The New England journal of medicine.

[16]  A. Halestrap.  The monocarboxylate transporter family—Structure and functional characterization , 2012, IUBMB life.

[17]  J. Pouysségur,et al.  CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors , 2011, Proceedings of the National Academy of Sciences.

[18]  Adam Ertel,et al.  Evidence for a stromal-epithelial “lactate shuttle” in human tumors , 2011, Cell cycle.

[19]  Sarah A. Stern,et al.  Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation , 2011, Cell.

[20]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[21]  R. Bristow,et al.  Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. , 2010, International journal of radiation oncology, biology, physics.

[22]  A. Halestrap,et al.  The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein , 2010, The Biochemical journal.

[23]  P. Oefner,et al.  Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. , 2009, Neuro-oncology.

[24]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[25]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[26]  L. Pellerin,et al.  Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway , 2007, Journal of neurochemistry.

[27]  J. Dancey.  Therapeutic targets: MTOR and related pathways , 2006, Cancer biology & therapy.

[28]  Masaki Kobayashi,et al.  Inhibitory effects of statins on human monocarboxylate transporter 4. , 2006, International journal of pharmaceutics.

[29]  H. Iwasaki,et al.  Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression , 2006, Pathology international.

[30]  A. Halestrap,et al.  The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism* , 2006, Journal of Biological Chemistry.

[31]  O. Thews,et al.  Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. , 2006, Neoplasia.

[32]  D. Meredith,et al.  Basigin (CD147) Is the Target for Organomercurial Inhibition of Monocarboxylate Transporter Isoforms 1 and 4 , 2005, Journal of Biological Chemistry.

[33]  A. Bonen,et al.  Isoform-specific regulation of the lactate transporters MCT1 and MCT4 by contractile activity. , 2000, American journal of physiology. Endocrinology and metabolism.

[34]  S. Bröer,et al.  The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.

[35]  A. Marette,et al.  Abundance and subcellular distribution of MCT1 and MCT4 in heart and fast-twitch skeletal muscles. , 2000, American journal of physiology. Endocrinology and metabolism.

[36]  J. Brown,et al.  Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. , 2000, Molecular medicine today.

[37]  Y. Hellsten,et al.  Effect of high-intensity exercise training on lactate/H+ transport capacity in human skeletal muscle. , 1999, The American journal of physiology.

[38]  N. Philp,et al.  Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[39]  H. Lyng,et al.  Correlation of high lactate levels in head and neck tumors with incidence of metastasis. , 1997, The American journal of pathology.

[40]  T. Nakano,et al.  Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma: MIB‐1 and PC10 labeling indices , 1996, Cancer.

[41]  A. Eastman,et al.  Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. , 1995, Seminars in cancer biology.

[42]  F. Demard,et al.  Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. , 1988, European journal of cancer & clinical oncology.

[43]  R. Teoule.  Radiation-induced DNA damage and its repair. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[44]  H. Bartelink,et al.  The value of postoperative radiotherapy as an adjuvant to radical neck dissection , 1983, Cancer.

[45]  W. Panje,et al.  Epidermoid Carcinoma of the Floor of the Mouth: Surgical Therapy vs Combined Therapy VS Radiation Therapy , 1980, Otolaryngology and head and neck surgery.

[46]  A. Halestrap.  The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. , 1975, The Biochemical journal.

[47]  R. Denton,et al.  Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by α-cyano-4-hydroxycinnamate (Short Communication) , 1974 .

[48]  Franz Wind,et al.  Über den Stoffwechsel von Tumoren im Körper , 1926, Klinische Wochenschrift.

[49]  S. Walenta,et al.  Lactate-An Integrative Mirror of Cancer Metabolism. , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[50]  Michael Baumann,et al.  Glycolytic metabolism and tumour response to fractionated irradiation. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[51]  L. Pellerin,et al.  Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain , 2005, Journal of neuroscience research.

[52]  B. Coche-Déquéant,et al.  Management of early oral cavity cancer. Experience of Centre Oscar Lambret. , 1994, European journal of cancer. Part B, Oral oncology.

[53]  R. Spiro,et al.  Failure in the neck following multimodality treatment for advanced head and neck cancer. , 1984, Head & neck surgery.